A | Ipi3 (n=523) | HDI (n=636) | Ipi10 (n=511) |
Corticosteroids, n (%) | 299 (57.2) | 66 (10.4) | 387 (75.7) |
Immunosuppressants*, n (%) | 28 (5.4) | 4 (0.6) | 42 (8.2) |
Hormones†, n (%) | 90 (17.2) | 40 (6.3) | 147 (28.8) |
Corticosteroids or immunosuppressants, n (%) | 300 (57.4) | 68 (10.7) | 388 (75.9) |
B | No irAE (n=115) | irAE grades 1 and 2 (n=525) | irAE grades 3, and 4 (n=371) |
Corticosteroids, n (%) | 18 (15.7) | 314 (59.8) | 341 (91.9) |
Immunosuppressants*, n (%) | 2 (1.7) | 10 (1.9) | 57 (15.4) |
Hormones†, n (%) | 4 (3.5) | 113 (21.5) | 119 (32.1) |
Corticosteroids or immunosuppressants, n (%) | 18 (15.7) | 315 (60.0) | 342 (92.2) |
*Infliximab, mycophenolate, cyclosporine and other.
†Thyroid hormone, hydrocortisone and testosterone.
HDI, high-dose interferon; Ipi3, ipilimumab 3 mg/kg; Ipi10, ipilimumab 10 mg/kg; irAE, immune-related adverse event.